EVERBLU CAPITAL

EverBlu Capital is an Australia-based investment bank that provides corporate advisory and capital market services to clients through its Everblu Corporate, Everblu Wealth and Everblu Research service offerings. The company combines Australian and International equity specialists to provide boutique services that have led to capital raises in excess of $150 Million for its clients. Everblu Capital has pioneered investment in the Australian medical cannabis industry through successful capital raising for ASX listed Creso Pharma. Through its subsidiary Everblu Research, the "AM Report" from Everblu Capital is a widely distributed report on global market developments.